no code implementations • 11 Mar 2020 • Ning An, Liuqi Jin, Huitong Ding, Jiaoyun Yang, Jing Yuan
Besides identifying a proteomic risk marker and further reinforce the link between metabolic risk factors and Alzheimer disease, this paper also suggests that apidonectin-linked pathways are a possible therapeutic drug target.